# Long-term Safety and Efficacy of TQH2722 Injection in the Treatment of Chronic Sinusitis With or Without Nasal Polyps

> **NCT06439381** · PHASE2 · RECRUITING · sponsor: **Chia Tai Tianqing Pharmaceutical Group Co., Ltd.** · enrollment: 120 (estimated)

## Conditions studied

- Chronic Rhinosinusitis

## Interventions

- **DRUG:** 300mg/600mg of TQH2722 injection

## Key facts

- **NCT ID:** NCT06439381
- **Lead sponsor:** Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-16
- **Primary completion:** 2026-06
- **Final completion:** 2026-06
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2026-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06439381

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06439381, "Long-term Safety and Efficacy of TQH2722 Injection in the Treatment of Chronic Sinusitis With or Without Nasal Polyps". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT06439381. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*